Guenter Mueller

Person

Sulzbach, DE

People

Patents Grantslast 30 patents

Information Patent Grant
PIM-3 kinase as a target for type 2 diabetes mellitus
- Patent number 8,580,251
- Issue date Nov 12, 2013
- Sanofi-Aventis Deutschland GmbH
- Marc Korn
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Saccharomyces cerevisiae yeast strain with functional expression of...
- Patent number 8,574,909
- Issue date Nov 5, 2013
- Sanofi-Aventis Deutschland GmbH
- Guenter Mueller
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Use of Saccharomyces cerevisiae erg4 mutants for expressing mammali...
- Patent number 8,298,812
- Issue date Oct 30, 2012
- Sanofi-Aventis Deutschland GmbH
- Guenter Mueller
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Glimepiride- and insulin-induced glycosylphosphatidylinositol-speci...
- Patent number 8,017,350
- Issue date Sep 13, 2011
- Sanofi-Aventis Deutschland GmbH
- Guenter Mueller
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted N-aminomethylene sulfonamides, production and use there...
- Patent number 7,781,613
- Issue date Aug 24, 2010
- sanofi-aventis
- Karl Schoenafinger
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Diphenylamine-substituted salicylthiazole derivatives and related c...
- Patent number 7,741,491
- Issue date Jun 22, 2010
- Sanofi-Aventis Deutschland GmbH
- Stefan Petry
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrimido[5,4-e][1,2,4]triazine-5-7-diones, processes for preparing...
- Patent number 7,737,144
- Issue date Jun 15, 2010
- Sanofi-Aventis Deutschland GmbH
- Stefan Petry
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
4-benzimidazol-2-yl-pyridazine-3-one-derivatives, production and us...
- Patent number 7,727,989
- Issue date Jun 1, 2010
- Sanofi-Aventis Deutschland GmbH
- Karl Schoenafinger
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyridazinone derivatives, methods for their production and their us...
- Patent number 7,709,466
- Issue date May 4, 2010
- Sanofi-Aventis Deutschland GmbH
- Swen Hoelder
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
PIM-3 kinase as a target for type 2 diabetes mellitus
- Patent number 7,629,126
- Issue date Dec 8, 2009
- Sanofi-Aventis Deutschland GmbH
- Marc Korn
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Use of Saccharomyces cerevisiae erg4 mutants for expressing mammali...
- Patent number 7,615,360
- Issue date Nov 10, 2009
- Sanofi-Aventis Deutschland GmbH
- Guenter Mueller
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Phosophoinositoglycan binding proteins
- Patent number 7,449,560
- Issue date Nov 11, 2008
- Sanofi-Aventis Deutschland GmbH
- Guenter Mueller
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Adenosine analogues and their use as pharmaceutical agents
- Patent number 7,265,111
- Issue date Sep 4, 2007
- Sanofi-Aventis Deutschland GmbH
- Antony Bigot
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Use of Saccharomyces cerevisiae erg4 mutants for expressing mammali...
- Patent number 7,244,821
- Issue date Jul 17, 2007
- Sanofi-Aventis Deutschland GmbH
- Guenter Mueller
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
PIM-3 kinase as a target for type 2 diabetes mellitus
- Patent number 7,227,006
- Issue date Jun 5, 2007
- Sanofi-Aventis Deutschland GmbH
- Marcus Korn
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Substituted an unsubstituted benzooxathiazoles and compounds derive...
- Patent number 7,211,592
- Issue date May 1, 2007
- Sanofi-Aventis Deutschland GmbH
- Stefan Petry
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bicyclic inhibitors of hormone sensitive lipase
- Patent number 7,208,504
- Issue date Apr 24, 2007
- Sanofi-Aventis Deutschland GmbH
- Stefan Petry
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted thiazole-benzoisothiazole dioxide derivatives, process...
- Patent number 7,094,794
- Issue date Aug 22, 2006
- Sanofi-Aventis Deutschland GmbH
- Stefan Petry
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Phosophoinositoglycan binding proteins
- Patent number 7,049,416
- Issue date May 23, 2006
- Sanofi-Aventis Deutschland GmbH
- Guenter Mueller
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-ones, their prepara...
- Patent number 6,596,742
- Issue date Jul 22, 2003
- Aventis Pharma Deutschland GmbH
- Stefan Petry
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Percyquinnin, a process for its production and its use as a pharmac...
- Patent number 6,596,518
- Issue date Jul 22, 2003
- Aventis Pharma Deutschland GmbH
- Cordula Hopmann
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Substituted and unsubstituted benzooxathiazoles and compounds deriv...
- Patent number 6,566,390
- Issue date May 20, 2003
- Aventis Pharma Deutschland GmbH
- Stefan Petry
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-ones, their prepara...
- Patent number 6,369,088
- Issue date Apr 9, 2002
- Aventis Pharma Deutschland GmbH
- Karl Schoenafinger
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inositolglycans having insulin-like action
- Patent number 6,004,938
- Issue date Dec 21, 1999
- Hoescht Aktiengesellschaft
- Wendelin Frick
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
PIM-3 Kinase as a Target for Type 2 Diabetes Mellitus
- Publication number 20140087969
- Publication date Mar 27, 2014
- Sanofi-Aventis Deutschland GmbH
- Marc Korn
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
USE OF SACCHAROMYCES CEREVISIAE ERG4 MUTANTS FOR EXPRESSING MAMMALI...
- Publication number 20100203617
- Publication date Aug 12, 2010
- Sanofi-Aventis Deutschland GmbH
- Guenter Mueller
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PIM-3 KINASE AS A TARGET FOR TYPE 2 DIABETES MELLITUS
- Publication number 20100041058
- Publication date Feb 18, 2010
- Sanofi-Aventis Deutschland GmbH
- Marc Korn
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
SUBSTITUTED N-AMINOMETHYLENE SULFONAMIDES, PRODUCTION AND USE THERE...
- Publication number 20080069851
- Publication date Mar 20, 2008
- Sanofi-Aventis Deutschland GmbH
- Karl SCHOENAFINGER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Pyrimido[5,4-e][1,2,4]triazine-5,7-diones, processes for preparing...
- Publication number 20080032984
- Publication date Feb 7, 2008
- Sanofi-Aventis Deutschland GmbH
- Stefan Petry
- C07 - ORGANIC CHEMISTRY
Information Patent Application
THE USE OF SACCHAROMYCES CEREVISIAE ERG4 MUTANTS FOR EXPRESSING MAM...
- Publication number 20080020419
- Publication date Jan 24, 2008
- Sanofi-Aventis Deutschland GmbH
- Guenter Mueller
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DIPHENYLAMINE-SUBSTITUTED SALICYLTHIAZOLE DERIVATIVES AND RELATED C...
- Publication number 20070191441
- Publication date Aug 16, 2007
- SANOFI-AVENTIS DEUTSCHLAND GMBH
- Stefan Petry
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PIM-3 KINASE AS A TARGET FOR TYPE 2 DIABETES MELLITUS
- Publication number 20070154919
- Publication date Jul 5, 2007
- Sanofi-Aventis Deutschland GmbH
- Marc Korn
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
GLIMEPIRIDE- AND INSULIN-INDUCED GLYCOSYLPHOSPHATIDYLINOSITOL-SPECI...
- Publication number 20070111263
- Publication date May 17, 2007
- Sanofi-Aventis Deutschland GmbH
- Guenter MUELLER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRIDAZINONE DERIVATIVES, METHODS FOR THEIR PRODUCTION AND THEIR US...
- Publication number 20070088041
- Publication date Apr 19, 2007
- Sanofi-Aventis Deutschland GmbH
- Swen Hoelder
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Phosophoinositoglycan binding proteins
- Publication number 20060160142
- Publication date Jul 20, 2006
- Sanofi-Aventis Deutschland GmbH
- Guenter Mueller
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of Saccharomyces cerevisiae Erg4 mutants for expressing mammali...
- Publication number 20050074845
- Publication date Apr 7, 2005
- Aventis Pharma Deutschland GmBH
- Guenter Mueller
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Substituted thiazole-benzoisothiazole dioxide derivatives, process...
- Publication number 20050070533
- Publication date Mar 31, 2005
- Aventis Pharma Deutschland GmBH
- Stefan Petry
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Substituted an unsubstituted benzooxathiazoles and compounds derive...
- Publication number 20050043373
- Publication date Feb 24, 2005
- Aventis Pharma Deutschland GmBH
- Stefan Petry
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Pyrimido[5,4-e][1,2,4]triazine-5,7-diones, processes for preparing...
- Publication number 20040242583
- Publication date Dec 2, 2004
- Aventis Pharma Deutschland GmBH
- Stefan Petry
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Phosophoinositoglycan binding proteins
- Publication number 20040229278
- Publication date Nov 18, 2004
- Guenter Mueller
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Novel adenosine analogues and their use as pharmaceutical agents
- Publication number 20040127434
- Publication date Jul 1, 2004
- Antony Bigot
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Novel bicyclic inhibitors of hormone sensitive lipase
- Publication number 20040127484
- Publication date Jul 1, 2004
- Aventis Pharma Deutschland GmBH
- Stefan Petry
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PIM-3 kinase as a target for type 2 diabetes mellitus
- Publication number 20040038246
- Publication date Feb 26, 2004
- Marc Korn
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Use of substituted 3-phenyl-5-alkoxy-3H-(1,3,4)-oxadizol-2-ones for...
- Publication number 20030236288
- Publication date Dec 25, 2003
- Karl Schoenafinger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Substituted and unsubstituted benzooxathiazoles and compounds deriv...
- Publication number 20030191161
- Publication date Oct 9, 2003
- Stefan Petry
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Substituted and unsubstituted benzooxathiazoles and compounds deriv...
- Publication number 20020055523
- Publication date May 9, 2002
- Stefan Petry
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Percyquinnin, a process for its production and its use as a pharmac...
- Publication number 20020039768
- Publication date Apr 4, 2002
- Cordula Hopmann
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Substituted 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-ones, their prepara...
- Publication number 20010031772
- Publication date Oct 18, 2001
- Karl Schoenafinger
- C07 - ORGANIC CHEMISTRY

Guenter Mueller

Person

Patents Grantslast 30 patents

PIM-3 kinase as a target for type 2 diabetes mellitus

Saccharomyces cerevisiae yeast strain with functional expression of...

Use of Saccharomyces cerevisiae erg4 mutants for expressing mammali...

Glimepiride- and insulin-induced glycosylphosphatidylinositol-speci...

Substituted N-aminomethylene sulfonamides, production and use there...

Diphenylamine-substituted salicylthiazole derivatives and related c...

Pyrimido[5,4-e][1,2,4]triazine-5-7-diones, processes for preparing...

4-benzimidazol-2-yl-pyridazine-3-one-derivatives, production and us...

Pyridazinone derivatives, methods for their production and their us...

PIM-3 kinase as a target for type 2 diabetes mellitus

Use of Saccharomyces cerevisiae erg4 mutants for expressing mammali...

Phosophoinositoglycan binding proteins

Adenosine analogues and their use as pharmaceutical agents

Use of Saccharomyces cerevisiae erg4 mutants for expressing mammali...

PIM-3 kinase as a target for type 2 diabetes mellitus

Substituted an unsubstituted benzooxathiazoles and compounds derive...

Bicyclic inhibitors of hormone sensitive lipase

Substituted thiazole-benzoisothiazole dioxide derivatives, process...

Phosophoinositoglycan binding proteins

Substituted 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-ones, their prepara...

Percyquinnin, a process for its production and its use as a pharmac...

Substituted and unsubstituted benzooxathiazoles and compounds deriv...

Substituted 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-ones, their prepara...

Inositolglycans having insulin-like action

Patents Applicationslast 30 patents

PIM-3 Kinase as a Target for Type 2 Diabetes Mellitus

USE OF SACCHAROMYCES CEREVISIAE ERG4 MUTANTS FOR EXPRESSING MAMMALI...

PIM-3 KINASE AS A TARGET FOR TYPE 2 DIABETES MELLITUS

SUBSTITUTED N-AMINOMETHYLENE SULFONAMIDES, PRODUCTION AND USE THERE...

Pyrimido[5,4-e][1,2,4]triazine-5,7-diones, processes for preparing...

THE USE OF SACCHAROMYCES CEREVISIAE ERG4 MUTANTS FOR EXPRESSING MAM...

DIPHENYLAMINE-SUBSTITUTED SALICYLTHIAZOLE DERIVATIVES AND RELATED C...

PIM-3 KINASE AS A TARGET FOR TYPE 2 DIABETES MELLITUS

GLIMEPIRIDE- AND INSULIN-INDUCED GLYCOSYLPHOSPHATIDYLINOSITOL-SPECI...

PYRIDAZINONE DERIVATIVES, METHODS FOR THEIR PRODUCTION AND THEIR US...

Phosophoinositoglycan binding proteins

Use of Saccharomyces cerevisiae Erg4 mutants for expressing mammali...

Substituted thiazole-benzoisothiazole dioxide derivatives, process...

Substituted an unsubstituted benzooxathiazoles and compounds derive...

Pyrimido[5,4-e][1,2,4]triazine-5,7-diones, processes for preparing...

Phosophoinositoglycan binding proteins

Novel adenosine analogues and their use as pharmaceutical agents

Novel bicyclic inhibitors of hormone sensitive lipase

PIM-3 kinase as a target for type 2 diabetes mellitus

Use of substituted 3-phenyl-5-alkoxy-3H-(1,3,4)-oxadizol-2-ones for...

Substituted and unsubstituted benzooxathiazoles and compounds deriv...

Substituted and unsubstituted benzooxathiazoles and compounds deriv...

Percyquinnin, a process for its production and its use as a pharmac...

Substituted 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-ones, their prepara...